null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-000950-23-FR

Enrollment

240

Registered

2013-07-24

Start date

2013-05-14

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10043777 Term: Thyroidectomy total System Organ Class: 100000004865

Interventions

Trade Name: PULMICORT Product Name: Budésonide Pharmaceutical Form: Nebuliser suspension

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 240 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 240

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: Before and after surgery then every day until its exit	—

Secondary

Measure	Time frame
Timepoint(s) of evaluation of this end point: Before and after surgery then every day until its exit	—

Countries

France

Contacts

Public ContactChef de projets recherche

CHU Dijon

maud.carpentier@chu-dijon.fr038029561833

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026